A randomized, crossover, controlled clinical trial of intermittent daytime transcutaneous electrical stimulation of the genioglossus in patients with OSA

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200061623

Enrollment

Unknown

Registered

2022-06-29

Start date

2022-07-01

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea

Interventions

Group A:Intermittent transcutaneous electrical stimulation during the day

Group B:sham stimulation

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Normal subjects; 2. Patients with simple snoring; 3. Patients with obstructive sleep apnea of different severity.

Exclusion criteria

Exclusion criteria: 1. Failure to sign written informed consent; 2. Implantation of cardiac pacemaker device; 3. Arrhythmia, especially without treatment; 4. Heart, liver, kidney and respiratory function damage; 5. Tumors and other chronic diseases; 6. Lack of independent behavior ability.

Design outcomes

Primary

Measure	Time frame
Apnea Hyponea Index (AHI);oxygen desaturation index (ODI);	—

Secondary

Measure	Time frame
Epworth Sleepiness Scale (ESS);Visual Analog Score;Adverse Reaction Questionnaire;blood oxygen saturation;	—

Countries

China

Contacts

Public ContactKe Hu

Renmin Hospital of Wuhan University

huke-rmhospital@163.com+86 18971035988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026